Expression of PD-L1 and VISTA in Intraductal Papillary Mucinous Neoplasm With Associated Invasive Carcinoma of the Pancreas.
Humans
B7-H1 Antigen
/ analysis
CD8-Positive T-Lymphocytes
/ pathology
Pancreatic Intraductal Neoplasms
/ pathology
Adenocarcinoma, Mucinous
/ pathology
Pancreatic Neoplasms
/ pathology
Pancreas
/ metabolism
Carcinoma, Pancreatic Ductal
/ pathology
Neoplasm Invasiveness
/ pathology
Tumor Microenvironment
PD-L1
VISTA
intraductal papillary mucinous neoplasm
intraductal papillary mucinous neoplasm with associated invasive carcinoma
macrophage
pancreatic cancer
prognosis
tumor immune microenvironment
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
04
11
2022
revised:
02
05
2023
accepted:
18
05
2023
medline:
25
9
2023
pubmed:
28
5
2023
entrez:
27
5
2023
Statut:
ppublish
Résumé
Early detection and treatment of invasive carcinoma arising in association with intraductal papillary mucinous neoplasm (IPMN), which is biologically and (epi)genetically distinct from conventional pancreatic ductal adenocarcinoma, provide an opportunity to improve the prognosis of this lethal disease. Despite the successful application of programmed death (ligand) 1 (PD-[L]1)-blocking strategies in numerous cancers, the immune microenvironment of IPMN with associated invasive carcinoma remains elusive. Here, we investigated CD8
Identifiants
pubmed: 37244388
pii: S0893-3952(23)00128-X
doi: 10.1016/j.modpat.2023.100223
pii:
doi:
Substances chimiques
B7-H1 Antigen
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100223Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.